trial · primary record
ALE.P02
Squamous Non-small-cell Lung Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 235 |
| Primary completion | 2028-08-15 |
| Primary endpoint | Number of Patients with Dose Limiting Toxicities (DLTs) |
| Registry ID | NCT06747585 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:51.177Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06747585
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.